DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Clorindione
Clorindione
Characterising the Risk of Major Bleeding in Patients With
)&F1y3x PHARMACEUTICAL APPENDIX to THE
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
Partial Agreement in the Social and Public Health Field
Pharmaceutical Appendix to the Tariff Schedule 2
Study Protocol
9719087.Pdf (3.190Mb)
Marrakesh Agreement Establishing the World Trade Organization
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
CHAPTER 1 General Introduction
Wo 2011/060944 A2
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
(12) United States Patent (10) Patent No.: US 6,641,831 B1 Schierholz (45) Date of Patent: Nov
Synthesis of Novel Indane-1,3-Dione Derivatives and Their Biological Evaluation As Anticoagulant Agents
Ep 3121271 A1
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Top View
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Electronic Counselling for Oral Anticoagulant Patients Khulud Tariq
WO 2016/170102 Al 27 October 2016 (27.10.2016) P O P C T
Customs Tariff - Schedule
Port EU Post
Review of the Square Box Symbol Uses
Pharmaceutical Compositions Comprising Prasugrel And
Pharmaceutical Appendix to the Tariff Schedule 2
Customs Tariff - Schedule Xxi - 1
Australian Statistics on Medicines 2009
Sokestrategi PICO 1.4 Dokument
EU PV & PE Research Network Under the Framework Service Contract (Nr
Pharmaceutical Appendix to the Tariff Schedule 2
Cannabinoid (PRECIPITANT)
Harmonized Tariff Schedule of the United States (2006) (Rev
WO 2U11/132171 Al
Anticoagulant D
Pharmaceutical Appendix to the Tariff Schedule 2
(12) United States Patent (10) Patent No.: US 8,946,219 B2 Conley Et Al
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Klasifikacija ATC 2021
Drug-Drug Interactions Between Vitamin K Antagonists
A2) United States Patent (10) Patent No.: US 8,440,636 B2
Novel Oral Anticoagulants Versus Vitamin K Antagonists for Patients with Left Ventricular
Anticoagulants for Acute Ischaemic Stroke (Review)
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
(12) Patent Application Publication (10) Pub. No.: US 2013/0095095 A1 Lines (43) Pub
Summary of Risk Management Plan for Orivast (Atorvastatin) Orion Corporation
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving